<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>n8k2516.htm
<DESCRIPTION>PFIZER INC. 8-K
<TEXT>
<HTML>
<HEAD>
<TITLE>Pfizer Inc. 8-K </TITLE>
<BODY bgColor=#ffffff>
<DIV align=right> </DIV>
<P align=center><STRONG>UNITED STATES</STRONG></P>
<P align=center><STRONG><FONT size=4>SECURITIES AND EXCHANGE COMMISSION</FONT></STRONG></P>
<P align=center><STRONG>Washington, D.C. 20549</STRONG></P>
<P align=center><STRONG>FORM 8-K</STRONG></P>
<P align=center>CURRENT REPORT </P>
<P align=center>PURSUANT TO SECTION 13 OR 15(d) OF THE<BR>
  SECURITIES EXCHANGE ACT OF 1934</P>
<P align=center>Date of Report (Date of earliest event reported): February 8, 2016</P>
<P align=center><STRONG>PFIZER INC.</STRONG><BR>
  (Exact name of registrant as specified in its charter)</P>
<TABLE width="87%" border=0>
  <TR>
    <TD width="43%">
      <DIV align=center><STRONG>Delaware</STRONG></DIV>
    </TD>
    <TD width="25%">
      <DIV align=center><STRONG>1-3619</STRONG></DIV>
    </TD>
    <TD width="32%">
      <DIV align=center><STRONG>13-5315170</STRONG></DIV>
    </TD>
  </TR>
  <TR>
    <TD width="43%">
      <DIV align=center>(State or other Jurisdiction of incorporation)</DIV>
    </TD>
    <TD width="25%">
      <DIV align=center>(Commission File Number)</DIV>
    </TD>
    <TD width="32%">
      <DIV align=center>(I.R.S. Employer Identification No.)</DIV>
    </TD>
  </TR>
  <TR>
    <TD width="43%">
      <BLOCKQUOTE>
        <P align=center><STRONG>235 East 42nd Street <BR>
          New York, New York<BR>
          </STRONG>(Address of principal executive offices)<STRONG><BR>
          </STRONG></P>
      </BLOCKQUOTE>
    </TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="32%">
      <DIV align=center><STRONG>10017</STRONG><BR>
        (Zip Code)</DIV>
    </TD>
  </TR>
</TABLE>
<BLOCKQUOTE>
  <BLOCKQUOTE>
    <P align=center> Registrant's telephone number, including area code:
    <DIV align=center> (212) 733-2323 <br>
      <strong><br>
      </strong><u>Not Applicable</u>	<br>
      (Former Name or Former Address, if changed since last report)<br>
    </DIV>
  </BLOCKQUOTE>
</BLOCKQUOTE>
<P align=left>Check the appropriate box below if the Form 8-K filing is intended
  to simultaneously satisfy the obligation of the registrant under any of the
  following provisions: </P>
<P> [&nbsp; &nbsp;] Written communication pursuant to Rule 425 under the Securities
  Act (17 CFR 230.425)</P>
<P> [&nbsp; &nbsp;] Soliciting material pursuant to Rule 14a-12 under the Exchange
  Act (17 CFR 240.14a-12)</P>
<P> [&nbsp; &nbsp;] Pre-commencement communications pursuant to Rule 14d-2(b)
  under the Exchange Act (17 CFR 240.14d-2(b))</P>
<P> [ &nbsp;&nbsp;] Pre-commencement communications pursuant to Rule 13e-4(c)
  under the Exchange Act (17 CFR 240.13e-4(c))</P>
<P>&nbsp;</P>
<table width="87%" border=0 height="217">
  <tr>
    <td width="13%" height="66"><b>Item 5.02</b></td>
    <td width="87%" height="66"><p><strong>Departure of Directors or Certain Officers; Election  of Directors; Appointment of Certain Officers; Compensatory Arrangements of  Certain Officers</strong></p></td>
  </tr>
  <tr>
    <td height="145" colspan="2">
    <p>On February  8, 2016, Pfizer Inc. (the &quot;Company&quot;) announced that Geno Germano, Group  President, Global Innovative Pharma Business, will be leaving the Company.&nbsp; The Company also announced that, effective immediately and through the closing of the pending  transaction between Pfizer and Allergan plc (&ldquo;Allergan&rdquo;), Pfizer&rsquo;s Global  Innovative Pharma business and its Vaccines, Oncology and Consumer Healthcare  business will operate separately under the leadership of Albert Bourla,  currently Group President, Vaccines, Oncology and Consumer Healthcare.&nbsp; The Company also announced  the expected executive leadership team for the combined Pfizer-Allergan organization  upon closing of the pending transaction with Allergan. <br>
      <br>
    The related  press release is filed herewith as Exhibit 99.1 and is incorporated herein by  reference.</p></td>
  </tr>
</table>
<p>&nbsp;</p>
<table width="80%" border=0>
  <tr>
    <td width="21%"><strong>Item 9.01</strong></td>
    <td width="75%"><strong> Financial Statements and Exhibits.</strong></td>
    <td width="4%">&nbsp;</td>
  </tr>
</table>
<table width="80%" border=0>
  <tr>
    <td width="24%">(d) Exhibits<br></td>
    <td width="71%">&nbsp;</td>
    <td width="5%">&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td><u>Exhibit No.</u></td>
    <td><u>Description</u></td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td>99.1</td>
    <td> Press Release dated February 8, 2016</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td width="24%">&nbsp;</td>
    <td width="71%">&nbsp;</td>
    <td width="5%">&nbsp;</td>
  </tr>
</table>
<p align="left">&nbsp;</p>
<p align="center"><STRONG>SIGNATURE</STRONG></p>
<P>Under the requirements of the Securities Exchange Act of 1934, the registrant
  has caused this report to be signed on its behalf by the authorized undersigned.</P>
<TABLE width="82%" border=0>
  <TR>
    <TD width="33%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="61%">
      <DIV align=left>PFIZER INC.</DIV>
    </TD>
  </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp; </TD>
  </TR>
  <TR>
    <TD height=41>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>
      <DIV align=left>By: <U>/s/ &nbsp;Margaret M. Madden</U><BR>
        Margaret M. Madden</DIV>
    </TD>
  </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>
      <DIV align=left>Title: Vice President and Corporate Secretary<br>
    </DIV></TD>
  </TR>
  <TR>
    <TD>Dated: February  8, 2016</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chief  Governance Counsel</TD>
  </TR>
</TABLE>
<p>&nbsp;</p>
<BLOCKQUOTE>
  <BLOCKQUOTE>
    <BLOCKQUOTE>
      <BLOCKQUOTE>
        <BLOCKQUOTE>
          <BLOCKQUOTE>
            <BLOCKQUOTE>&nbsp;</BLOCKQUOTE>
          </BLOCKQUOTE>
          <p><b>EXHIBIT INDEX</b></p>
        </BLOCKQUOTE>
      </BLOCKQUOTE>
    </BLOCKQUOTE>
  </BLOCKQUOTE>
</BLOCKQUOTE>
<table width="81%" border=0>
  <tr>
    <td width="17%">
      <p><b>Number</b></p>
    </td>
    <td width="83%"><b>Description</b></td>
  </tr>
  <tr>
    <td width="17%">99.1</td>
    <td width="83%"> Press Release dated February 8, 2016</td>
  </tr>
</table>
<P align=center>&nbsp;</P>
</TEXT>
</DOCUMENT>